Eleven Biotherapeutics

SEC Filings
 

 
SEC Filings
Date Filed Filing Description View
April 7, 2017 SC 13D/A amended general statement of beneficial ownership HTML PDF XLS Add to Briefcase
April 7, 2017 DEFA14A definitive additional proxy materials HTML PDF XLS Add to Briefcase
April 7, 2017 DEF 14A definitive proxy statement HTML PDF XLS Add to Briefcase
April 5, 2017 4 decillis, arthur HTML PDF XLS Add to Briefcase
April 5, 2017 4 hurly, stephen a HTML PDF XLS Add to Briefcase
April 5, 2017 4 mccabe, john j HTML PDF XLS Add to Briefcase
April 3, 2017 8-K current report HTML PDF XLS Add to Briefcase
March 24, 2017 10-K annual report HTML PDF XLS XBRL Add to Briefcase
March 24, 2017 8-K current report HTML PDF XLS Add to Briefcase
March 6, 2017 8-K current report HTML PDF XLS Add to Briefcase
1
... NextLast
Add to Briefcase = add PDF file to Briefcase
NASDAQ: EBIO
Price:
1.92
Change:
0.00
Day High:
1.96
Day Low:
1.90
Volume:
89,430
4:00 PM ET on April 26, 2017
Delayed at least 20 minutes.